The global Urology Lasers Market size is anticipated to reach
USD 1.4 billion by 2026, according to a new report by Grand View Research,
Inc., registering a CAGR of 5.7% over the forecast period. The increasing
demand for minimally invasive surgeries, rise in the number of patients
suffering from urinary calculi, and technological advancements in urology
lasers is anticipated to boost the market growth.
Further key findings from the study suggest:
The demand for lasers in urology is rising due to the increasing
preference for minimally invasive surgeries as these procedures reduce
morbidity, dysfunction, and have the ability to ablate prostate tissue with
minimal hemorrhage or bleeding. They also offer advantages such as quicker
recovery from surgery, lower risk of bleeding, and enable a shorter bladder
catheterization time, sometimes even eliminating the need for bladder
catheterization completely. These procedures are also characterized by more
stable outcomes and lower number of reoperations. Lasers are used for the
treatment of various urological disorders such as Benign Prostatic Hyperplasia
(BPH) and urolithiasis. According to the American Urological Association,
around 8.8% of the U.S. population are affected by urinary stones. Thus,
increasing prevalence of urological disorders such as urolithiasis,
nephrolithiasis, and BPH are also contributing toward market growth.
With equipment advancement, better understanding of urologists’
needs on the part of producers, and growing experience of operators, these
treatments are a favorable alternative to traditional surgical procedures.
Technological advancements in urology lasers have expanded the portfolio for
the types used in various surgeries, including urologic operations. For
instance, holmium (Ho:YAG) lithotripters were traditionally used with two
parameters, pulse frequency and pulse energy, to define the duration of
lithotripsy. With technological advancements, high-powered high-frequency
long-pulse Ho:YAG lithotripters are now available. These enable ultra-high
pulse frequencies (up to 80 Hz), further speeding up the dusting lithotripsy
procedure.
Browse Details of Report @
https://www.grandviewresearch.com/industry-analysis/urology-laser-market
https://www.grandviewresearch.com/industry-analysis/urology-laser-market
Further key findings from the study suggest:
- The
Benign Prostatic Hyperplasia (BPH) segment dominated the market in 2018
owing to the increasing prevalence of BPH in men and rise in demand for
minimally invasive surgeries
- The
thulium system segment is expected to register the highest CAGR during the
forecast period as it is a safe and highly effective system in terms of
tissue resection speed and preventing blood loss
- North
America dominated the overall market with the highest revenue share in
2018 owing to the increasing prevalence of urological disorders such as
urolithiasis and BPH coupled with growing awareness of this treatment in
the region
- Key
players in the urology lasers market are introducing innovative and
technologically enhanced products to gain competitive advantage in the
industry. For instance, in 2017, Lumenis launched Moses Holmium Technology
to reduce retropulsion during lithotripsy procedure. It is designed to
minimize ureteric as well as bladder stone migration. It reduces stone
retropulsion and, in turn, stone migration, leading to a more efficient
treatment and greater physician control over the procedure.
About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment